Rwanda-based medical procurement platform raises investment
Viebeg Medical has announced a new investment from J&J Impact Ventures and Sanofi Global Health Unit Impact Fund.
For the best experience and to access our Connect industry chat platform, download the Africa Private Equity News app: Android | iOS
Viebeg Medical has announced a new investment from J&J Impact Ventures, an impact fund within the Johnson & Johnson Foundation, and Sanofi Global Health Unit Impact Fund.
Serving more than 1,000 hospitals, clinics, pharmacies and healthcare providers in Rwanda, Kenya and the Democratic Republic of the Congo, Viebeg is a healthtech company that provides medical supplies and equipment as well as pharmaceuticals through VieProcure, an innovative data-driven procurement solution.
Founded in 2018, Viebeg previously raised more than $2.5 million from VC firms such as Beyond Capital Ventures, Global Ventures, Angaza Capital, Founders Factory Africa, Norrsken and others. The start-up was founded by chief executive officer, Tobias Reiter and chief commercial officer, Alex Musyoka.
“Through the past three years of operations at Viebeg, our team has identified large inefficiencies when it comes to the procurement decisions of healthcare providers across the East and Central African region. As a result, we are leveraging our healthcare distribution and technology expertise to build a world-class health demand simulation model (HDSM), beginning in Rwanda, the market where Viebeg has operated the longest. Our HDSM model identifies the current healthcare demand, compares it to the supply of health services in the region, calculates the profitability of each unit of medical equipment, and then supports healthcare providers in making optimal procurement decisions, translating to better quality and more affordable patient outcomes,” says CEO, Tobias Reiter.
“We are excited to play a role in Viebeg’s scale-up journey as an investor and partner through our impact fund,” said Jon Fairest, head of the global health unit at Sanofi. “Viebeg has demonstrated the value of its model in disrupting supply chain challenges to improve accessibility and affordability of quality and essential medical equipment in resource in constrained health systems, and we look forward to supporting their further expansion in pharmacies. We recognise the importance of investing in local entrepreneurial businesses that strengthen and support sustainable healthcare delivery and improve outcomes. Our global health unit is dedicated to improving access to sustainable healthcare for vulnerable populations with the highest unmet medical needs.”
* Subscribe to Africa Private Equity News’ monthly Dealmaker’s Log for a database of the reported investment deals, exits and fundraising closes. Click here for more information.